AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
19:17
The PSD-AUR amendment that targets Dominic Fritz, compared by Cătălin Drulă to Emergency Ordinance 13 and the risk of 800 million euros from the PNRR.
19:00
Flavia Boghiu, former USR vice mayor of Brașov, definitively acquitted in the "Catacombs" case.
18:55
Radu Miruță is asking Grindeanu to include on the agenda the USR project that prohibits the closure of energy production capacities without alternatives.
18:54
A man was accused of blackmail after he demanded 600,000 euros from his former employer, threatening that he would shoot his son if he did not receive the money.
18:45
The Russian embassy in Italy accused Ukraine of the bombing attack at a restaurant in Moscow, which resulted in five deaths and 19 injuries.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
